$62.22
▼ $-0.15
(-0.24%)
Vol 2.4M
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$25.9B
P/E
35.9
ROE
29.8%
Margin
16.0%
D/E
91.76
Beta
1.49
52W
$54–$93
Wall Street Consensus
37 analysts · Apr 202615
Strong Buy
17
Buy
4
Hold
1
Sell
0
Strong Sell
86.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.66 | $0.45 | $-0.21 |
| Sep 2025 | $0.58 | $0.61 | +$0.03 |
| Jun 2025 | $0.45 | $0.48 | +$0.03 |
| Mar 2025 | $0.33 | $0.32 | $-0.01 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.0B | $1.2B | $1.2B | $1.3B |
| Net Income | $151.7M | $105.4M | $179.8M | $283.8M | $267.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 25.6% | 25.6% | 25.6% | 29.8% | 29.8% | 29.8% |
| P/E (TTM) | 59.89 | 55.71 | 44.98 | 31.51 | 34.88 | 35.92 |
| Net Margin | 15.5% | 13.3% | 13.3% | 16.0% | 16.0% | 16.0% |
| Gross Margin | 59.5% | 60.0% | 60.0% | 60.2% | 60.2% | 60.2% |
| D/E Ratio | 97.21 | 97.21 | 97.21 | 91.76 | 91.76 | 91.76 |
| Current Ratio | 1.52 | 1.52 | 1.52 | 1.56 | 1.56 | 1.56 |
Key Ratios
ROA (TTM)
10.3%
P/S (TTM)
5.73
P/B
14.4
EPS (TTM)
$1.77
CF/Share
$1.28
Rev Growth 3Y
+18.1%
52W High
$93.25
52W Low
$54.11
$54.11
52-Week Range
$93.25
Financial Health
Free Cash Flow
$192.1M
Net Debt
$472.0M
Cash
$917.7M
Total Debt
$1.4B
As of Dec 31, 2025
How does DXCM compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
DXCM valuation vs Health Care peers
P/E ratio
35.9
▲
17%
above
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
5.7
▲
122%
above
peers
(2.6)
vs Peers
vs Industry
Overvalued
P/B ratio
14.5
▲
420%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
DXCM profitability vs Health Care peers
ROE
29.8%
▲
177%
above
peers
(-38.5%)
vs Peers
vs Industry
Top tier
Net margin
16.0%
▲
165%
above
peers
(-24.7%)
vs Peers
vs Industry
Top tier
Gross margin
60.2%
▲
14%
above
peers
(52.9%)
vs Peers
vs Industry
In line
ROA
10.3%
▲
148%
above
peers
(-21.2%)
vs Peers
vs Industry
Top tier
DXCM financial health vs Health Care peers
D/E ratio
91.8
▲
376%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
1.6
▼
28%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲
42%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
DXCM fundamentals radar
DXCM
Peer median
Industry
DXCM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
DXCM vs peers: key metrics
Related Signals
Latest AI Opinion
Grok
BUY
Price action shows a recent dip from $73.78 on 2026-03-02 to $65.94 last week and now $63.32 near the session low of $63.27, presenting a potential good entry point on this pullback within the broader recovery from November 2025 lows …
Mar 27, 2026Insider Activity
NeutralBuys
0
Sells
0
BROWN MICHAEL JON
Officer · Mar 16
1700 shs
COLEMAN JON
Officer · Mar 06
43897 shs
SYLVAIN JEREME M
Chief Financial Officer · Mar 06
48774 shs
LEACH JACOB STEVEN
Chief Executive Officer · Mar 06
104516 shs
STERN SADIE
Officer · Mar 06
39019 shs
SAYER KEVIN R
Officer and Director · Mar 06
32749 shs
BROWN MICHAEL JON
Officer · Mar 06
39019 shs
HELLER BRIDGETTE P
Director · Feb 12
1012 shs
SYLVAIN JEREME M
Chief Financial Officer · Jan 29
7123 shs
LEACH JACOB STEVEN
Chief Executive Officer · Jan 29
8310 shs
Last 90 days
Top Holders
Top 5: 34.7%Vanguard Group Inc
12.75%
$3.1B
Blackrock Inc.
10.35%
$2.5B
State Street Corporation
4.70%
$1.1B
BAILLIE GIFFORD & CO
4.04%
$968.1M
Geode Capital Management, L…
2.86%
$685.1M
As of Dec 31, 2025
Latest News
No related news yet